Opioid formulations with sequestered naltrexone: a perspective review. - Wikidata - wikimedia - TriplyDB

Opioid formulations with sequestered naltrexone: a perspective review.

Opioid formulations with sequestered naltrexone: a perspective review.

http://www.wikidata.org/entity/Q33949447

about

Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain.

P2860

Q38851461-0B9CC755-B4D6-4EB3-89F0-271A0A5EFF7F

P2860

Opioid formulations with sequestered naltrexone: a perspective review.

http://www.wikidata.org/entity/Q33949447

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Opioid formulations with sequestered naltrexone: a perspective review.

@ast

Opioid formulations with sequestered naltrexone: a perspective review.

@en

type

label

Opioid formulations with sequestered naltrexone: a perspective review.

@ast

Opioid formulations with sequestered naltrexone: a perspective review.

@en

prefLabel

Opioid formulations with sequestered naltrexone: a perspective review.

@ast

Opioid formulations with sequestered naltrexone: a perspective review.

@en

P1433

Q33949447-2659E881-C9F1-4FAC-9366-C8E11562E93F

P1476

Q33949447-894CB92F-421E-4992-820B-FD863F3CBC61

P2093

Q33949447-20FD086B-F2DA-4EFA-B562-8E7288BC52E2

Q33949447-89507C60-81C4-40C3-A177-3E006391BFF8

Q33949447-95DCD082-F400-427E-BC8C-DAFB3A8B4E0E

P2860

Q33949447-02B78E17-830C-4F25-92EC-267140C2FE15

Q33949447-31B17676-17C9-421F-8811-72C721D87A83

Q33949447-3612B40D-C8C4-4978-A1DA-50043BFB7F19

Q33949447-403E88C6-E3A8-4BF5-A940-61F365D17F13

Q33949447-698EE15D-43BA-4E73-B1D5-C936D9B00D83

Q33949447-6BB4D4D6-8FF2-41B6-BDC0-B5374C90D065

Q33949447-6E536D38-07D6-45B1-85B9-85EC336C310E

Q33949447-81D9A659-3154-4EE5-863E-7543A4BBC50A

Q33949447-9876F198-DEB3-4655-8371-6D7E126450BC

Q33949447-A6DD4580-B018-401D-AE2F-C5BF0ED724AC

P304

Q33949447-D2CEBA39-6FC4-4809-BD83-95781D154C94

P31

Q33949447-39264A8B-ED5A-4C17-A8F6-831860398FD2

P356

Q33949447-1AE62B3A-1FF2-43D4-8223-E24B73A64F20

P433

Q33949447-BBC5FC86-1250-4FFD-AF78-F664EA52BC90

P478

Q33949447-E71E4D90-EF0E-44B0-B8D8-314734123B53

P577

Q33949447-46E3FCB5-A33C-475D-B988-802436F15F4E

P698

Q33949447-4BBB1459-AB3F-4ACB-9012-3CC1186B5267

P921

Q33949447-899C9408-F307-4BC1-B31D-7948329CE00B

P932

Q33949447-33D0EE8D-D60C-47D4-9E69-C2296106B955

P356

2042098614526769

P1433

Therapeutic advances in drug safety

P1476

Opioid formulations with sequestered naltrexone: a perspective review.

@en

P2093

Joseph V Pergolizzi

http://www.w3.org/2001/XMLSchema#string

Robert B Raffa

http://www.w3.org/2001/XMLSchema#string

Robert Taylor

http://www.w3.org/2001/XMLSchema#string

P2860

Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.

Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users.

Foundations of opioid risk management.

Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.

Update on tamper-resistant drug formulations.

Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltrexone, in patients with chronic, moderate to severe pain.

ALO-01 (morphine sulfate and naltrexone hydrochloride) extended-release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safety.

Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.

Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex.

CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

P304

129-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042098614526769

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25083268

http://www.w3.org/2001/XMLSchema#string

P921

P932

4110852

http://www.w3.org/2001/XMLSchema#string